DE69433934D1 - Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA - Google Patents

Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA

Info

Publication number
DE69433934D1
DE69433934D1 DE69433934T DE69433934T DE69433934D1 DE 69433934 D1 DE69433934 D1 DE 69433934D1 DE 69433934 T DE69433934 T DE 69433934T DE 69433934 T DE69433934 T DE 69433934T DE 69433934 D1 DE69433934 D1 DE 69433934D1
Authority
DE
Germany
Prior art keywords
compositions
methods
recombinant dna
protein production
increased protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433934T
Other languages
English (en)
Other versions
DE69433934T2 (de
Inventor
Hermann Oppermann
Haimanti Dorai
Paul Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker Corp
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stryker Corp filed Critical Stryker Corp
Application granted granted Critical
Publication of DE69433934D1 publication Critical patent/DE69433934D1/de
Publication of DE69433934T2 publication Critical patent/DE69433934T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69433934T 1993-10-25 1994-10-21 Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA Expired - Lifetime DE69433934T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US143497 1993-10-25
US08/143,497 US5585237A (en) 1993-10-25 1993-10-25 Methods and compositions for high protein production from recombinant DNA
PCT/US1994/012063 WO1995011983A1 (en) 1993-10-25 1994-10-21 Methods and compositions for high protein production from recombinant dna

Publications (2)

Publication Number Publication Date
DE69433934D1 true DE69433934D1 (de) 2004-09-09
DE69433934T2 DE69433934T2 (de) 2005-09-08

Family

ID=22504345

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433934T Expired - Lifetime DE69433934T2 (de) 1993-10-25 1994-10-21 Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA

Country Status (6)

Country Link
US (3) US5585237A (de)
EP (1) EP0725829B1 (de)
JP (1) JP2004194681A (de)
CA (1) CA2171759C (de)
DE (1) DE69433934T2 (de)
WO (1) WO1995011983A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258494A (en) * 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US7429484B2 (en) * 1989-02-23 2008-09-30 Stryker Corporation Nucleic acid molecules encoding osteogenic proteins
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US5834188A (en) * 1995-07-26 1998-11-10 Creative Biomolecule, Inc. Methods and compositions for identifying morphogen analogs
US6103491A (en) * 1995-07-26 2000-08-15 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US5932716A (en) * 1995-07-26 1999-08-03 Creative Biomolecules, Inc. Morphogen-responsive regulatory elements
US7306903B1 (en) 1995-07-26 2007-12-11 Curis, Inc. Methods and compositions for identifying morphogen analogs
US6090544A (en) * 1995-07-26 2000-07-18 Creative Biomolecules, Inc. Methods and compositions for identifying morphogen analogs
US5869041A (en) * 1996-01-12 1999-02-09 The Miriam Hospital Delivery of bioactive compounds to an organism
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US6090393A (en) * 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
US6156567A (en) * 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
CA2285382C (en) * 1997-04-04 2008-03-25 Barnes-Jewish Hospital Neocartilage and methods of use
DE69826854T2 (de) 1997-05-05 2006-02-02 Curis, Inc., Cambridge Therapien zur behandlung von akutem nierenversagen
CA2291514C (en) 1997-05-30 2011-07-12 Creative Biomolecules, Inc. Methods for evaluating tissue morphogenesis and activity
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
DE69840361D1 (de) 1997-07-30 2009-01-29 Univ Emory Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
US6077987A (en) * 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
DE19816186A1 (de) * 1998-04-14 1999-10-21 Univ Muenchen L Maximilians GDNF-kodierende DNA, Teile davon und GDNF-Varianten
US7147839B2 (en) 1998-05-29 2006-12-12 Curis, Inc. Methods for evaluating tissue morphogenesis and activity
US6156514A (en) * 1998-12-03 2000-12-05 Sunol Molecular Corporation Methods for making recombinant cells
ES2568899T3 (es) * 1999-04-09 2016-05-05 Kyowa Hakko Kirin Co., Ltd. Procedimiento para controlar la actividad de una molécula inmunofuncional
JP4668498B2 (ja) * 1999-10-19 2011-04-13 協和発酵キリン株式会社 ポリペプチドの製造方法
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
JPWO2003084569A1 (ja) 2002-04-09 2005-08-11 協和醗酵工業株式会社 抗体組成物含有医薬
EP1739179A1 (de) * 2005-06-30 2007-01-03 Octapharma AG Serumfreie stabile Transfektion und Produktion von rekombinanten humanen Proteinen in humanen Zelllinien
KR101171384B1 (ko) * 2006-06-19 2012-08-10 한국과학기술원 유전자의 단계적 발현 네트워크 및 이를 이용한 세포표식방법
US8017325B2 (en) 2007-02-01 2011-09-13 Centocor Ortho Biotech Inc. Selection of high-producing cell lines
CA2688232A1 (en) * 2007-05-25 2008-12-04 Induce Biologics Inc. A method of enhancing recombinant protein production
GB0802224D0 (en) * 2008-02-06 2008-03-12 Inst Superiore Di Sanito Process for the production of vaccine components
CA2653866A1 (en) * 2008-07-03 2010-01-03 Induce Biologics Inc. Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness
US8398768B2 (en) * 2009-05-14 2013-03-19 Corning Incorporated Methods of making an article of semiconducting material on a mold comprising semiconducting material
CN110856751A (zh) 2018-08-24 2020-03-03 合成免疫股份有限公司 包含核酸及tcr修饰的免疫细胞的治疗剂及其应用
WO2023277069A1 (ja) 2021-06-30 2023-01-05 株式会社レプリテック マイナス鎖ｒｎａウイルスベクターの製造方法および製造されたマイナス鎖ｒｎａウイルスベクター

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656134A (en) * 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
EP0221955A4 (de) * 1985-05-01 1988-12-22 Genetics Inst Hochstufige verstärkung und expression von exogener dns.
EP0247145B1 (de) * 1985-11-05 1992-02-26 Genetics Institute, Inc. Vielfach amplifizierbare vektoren für hohe expression exogener dns
IL80511A0 (en) * 1985-11-05 1987-02-27 Genetics Inst Multiply amplifiable vectors for high level expression of exogenous dna
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US5002874A (en) * 1987-09-17 1991-03-26 Genetics Institute, Inc. Genetically engineered eucaryotic host cells capable of expressing modified forms of eIF-2α
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
GB8900483D0 (en) * 1989-01-10 1989-03-08 Celltech Ltd Recombinant dna method
EP0494225A4 (en) * 1989-09-27 1993-04-28 Us Health Human esophageal epithelial cell lines
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA

Also Published As

Publication number Publication date
JP2004194681A (ja) 2004-07-15
DE69433934T2 (de) 2005-09-08
WO1995011983A1 (en) 1995-05-04
CA2171759C (en) 2007-04-17
EP0725829B1 (de) 2004-08-04
AU8085994A (en) 1995-05-22
EP0725829A1 (de) 1996-08-14
AU685188B2 (en) 1998-01-15
US5712119A (en) 1998-01-27
JP3570721B2 (ja) 2004-09-29
US5614385A (en) 1997-03-25
JPH09504175A (ja) 1997-04-28
CA2171759A1 (en) 1995-05-04
US5585237A (en) 1996-12-17

Similar Documents

Publication Publication Date Title
DE69433934D1 (de) Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA
DE69019074T2 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
DE69407638D1 (de) Verfahren zur Fraktionierung von Blutmaterial
ATE230939T1 (de) Verfahren zur herstellung von plastifizierte proteinhaltige stoffe und zusammensetzungen daraus
DE69632887D1 (de) Verfahren zur zweckmässige Herstellung von Transglutaminase durch DNA-Rekombination
ATE233049T1 (de) Zusammensetzung und verfahren zur kontrolle von schädlichen bio-organismen
DE69637385D1 (de) DNS-Segmente und Verfahren zur Erhöhung von Polysaccharid-Produktion
DE69818446D1 (de) Kristallines Titan-Zinn-Silikalit Molekularsieb und Verfahren zur Epoxidierung von Olefinen
DE59804785D1 (de) Verbessertes Verfahren zur Stabilisierung von Proteinen
DE69227621T2 (de) Verfahren zur Raffinierung von Zein
DE69728802D1 (de) Wirkstoffimmobilisierte Partikel und Verfahren zur Reinigung von Proteinen
DE932679T1 (de) Verfahren und zusammensetzungen zur verabreichung und expression von interferon-alpha nukleinsäuren
DE69632904D1 (de) Kopräzipitat und methode zur extraktion von nukleinsäuren
DE69602355D1 (de) Verfahren und zusammensetzung zur reinigung von oberflächen
DE69404494D1 (de) Verfahren zur Verminderung der schlechten Geruch von Dauerwellen
DE59304907D1 (de) Verfahren zur entklebung und koagulation von lacken
DE69816622D1 (de) Verfahren zur Steigerung der Expression von Fremdproteinen
DE69010155D1 (de) Verfahren zur Trennung von Aminosäuren.
DE68906932D1 (de) Verfahren zur reinigung und isolierung carboxyl-endstaendiger peptide.
DE69738323D1 (de) Verfahren zur verringerung der abbaubarkeit von futterprotein
DE69618536D1 (de) Verfahren zur Inaktivierung von Viren in Proteinen
DE69434914D1 (de) Verfahren und zusammensetzungen zur herstellung von rekombinantem osteogenischem protein
DE69836083D1 (de) Verfahren zur kaskadierung von v5 schnittstellen
DE69530176T2 (de) Verfahren zur Herstellung von Protein
DE68910036T2 (de) Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition